1. Home
  2. RNXT vs CMBM Comparison

RNXT vs CMBM Comparison

Compare RNXT & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • CMBM
  • Stock Information
  • Founded
  • RNXT 2012
  • CMBM 2011
  • Country
  • RNXT United States
  • CMBM United States
  • Employees
  • RNXT N/A
  • CMBM N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • CMBM Radio And Television Broadcasting And Communications Equipment
  • Sector
  • RNXT Health Care
  • CMBM Technology
  • Exchange
  • RNXT Nasdaq
  • CMBM Nasdaq
  • Market Cap
  • RNXT 31.6M
  • CMBM 39.5M
  • IPO Year
  • RNXT 2021
  • CMBM 2019
  • Fundamental
  • Price
  • RNXT $1.12
  • CMBM $1.37
  • Analyst Decision
  • RNXT Strong Buy
  • CMBM Strong Buy
  • Analyst Count
  • RNXT 1
  • CMBM 3
  • Target Price
  • RNXT $9.00
  • CMBM $5.50
  • AVG Volume (30 Days)
  • RNXT 202.5K
  • CMBM 207.8K
  • Earning Date
  • RNXT 03-31-2025
  • CMBM 02-18-2025
  • Dividend Yield
  • RNXT N/A
  • CMBM N/A
  • EPS Growth
  • RNXT N/A
  • CMBM N/A
  • EPS
  • RNXT N/A
  • CMBM N/A
  • Revenue
  • RNXT N/A
  • CMBM $172,215,000.00
  • Revenue This Year
  • RNXT N/A
  • CMBM N/A
  • Revenue Next Year
  • RNXT N/A
  • CMBM $16.49
  • P/E Ratio
  • RNXT N/A
  • CMBM N/A
  • Revenue Growth
  • RNXT N/A
  • CMBM N/A
  • 52 Week Low
  • RNXT $0.77
  • CMBM $0.64
  • 52 Week High
  • RNXT $1.86
  • CMBM $4.92
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 36.31
  • CMBM 70.71
  • Support Level
  • RNXT $1.09
  • CMBM $1.11
  • Resistance Level
  • RNXT $1.40
  • CMBM $1.69
  • Average True Range (ATR)
  • RNXT 0.10
  • CMBM 0.14
  • MACD
  • RNXT -0.03
  • CMBM 0.04
  • Stochastic Oscillator
  • RNXT 8.51
  • CMBM 71.01

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About CMBM Cambium Networks Corporation

Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.

Share on Social Networks: